ESPRIT study design and outcomes – a critical appraisal
ESPRIT study design and outcomes – a critical appraisal
About this item
Full title
Author / Creator
Publisher
England: Informa UK Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa UK Ltd
Subjects
More information
Scope and Contents
Contents
ABSTRACT
Evidence is needed to guide therapeutic decisions on patients who had ischaemic cerebral events. The recently published European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT), an open-label randomised controlled study, compared long-term treatment of patients randomised to aspirin 30–325 mg daily with (n = 1363)...
Alternative Titles
Full title
ESPRIT study design and outcomes – a critical appraisal
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_informahealthcare_journals_10_1185_030079906X167291
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_informahealthcare_journals_10_1185_030079906X167291
Other Identifiers
ISSN
0300-7995
E-ISSN
1473-4877
DOI
10.1185/030079906X167291
